Skip to main content
Midas Edge

FENNEC PHARMACEUTICALS INC.

For the period ended Sep 30, 2025. Filed Nov 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 13, 2025

FENC$10.83+10.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Page
PART I: FINANCIAL INFORMATION3
​​
Item 1. Condensed Consolidated Financial Statements3
​​
Condensed Consolidated Balance Sheets (Unaudited) as of September 30, 2025, and December 31, 20243
​​
Condensed Consolidated Statements of Operations (Unaudited) for the Three and Nine Months Ended September 30, 2025 and 20244
​​
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) for the Three and Nine Months Ended September 30, 2025 and 20245
​​
Condensed Consolidated Statements of Cash Flows (Unaudited) for the Nine Months Ended September 30, 2025 and 20246
​​
Notes to the Condensed Consolidated Financial Statements7
​​
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations24
​​
Item 3. Quantitative and Qualitative Disclosures about Market Risk33
​​
Item 4. Controls and Procedures33
​​
​​
PART II: OTHER INFORMATION33
​​
Item 1. Legal Proceedings33
​​
Item 1A. Risk Factors35
​​
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds35
​​
Item 3. Defaults Upon Senior Securities35
​​
Item 4. Mine Safety Disclosures35
​​
Item 5. Other Information35
​​
Item 6. Exhibits35
​​
Signatures37
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.